142 related articles for article (PubMed ID: 29664682)
1. Long-Term Maintenance Effect of Qing Dai for Ulcerative Colitis.
Suzuki H; Mizokami Y; Gosho M; Kaneko T; Matsui H; Yanaka A
J Altern Complement Med; 2018 Nov; 24(11):1130-1131. PubMed ID: 29664682
[No Abstract] [Full Text] [Related]
2. Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.
Sugimoto S; Naganuma M; Kiyohara H; Arai M; Ono K; Mori K; Saigusa K; Nanki K; Takeshita K; Takeshita T; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hisamatsu T; Inoue N; Ogata H; Iwao Y; Kanai T
Digestion; 2016; 93(3):193-201. PubMed ID: 26959688
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.
Suzuki H; Kaneko T; Mizokami Y; Narasaka T; Endo S; Matsui H; Yanaka A; Hirayama A; Hyodo I
World J Gastroenterol; 2013 May; 19(17):2718-22. PubMed ID: 23674882
[TBL] [Abstract][Full Text] [Related]
4. Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).
Misumi K; Ogo T; Ueda J; Tsuji A; Fukui S; Konagai N; Asano R; Yasuda S
Intern Med; 2019 Feb; 58(3):395-399. PubMed ID: 30210129
[TBL] [Abstract][Full Text] [Related]
5. Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases.
Kondo S; Araki T; Okita Y; Yamamoto A; Hamada Y; Katsurahara M; Horiki N; Nakamura M; Shimoyama T; Yamamoto T; Takei Y; Kusunoki M
Clin J Gastroenterol; 2018 Aug; 11(4):268-272. PubMed ID: 29549501
[TBL] [Abstract][Full Text] [Related]
6. Blue Polypoid Colorectal Lesions in a Woman With Ulcerative Colitis Taking Qing-Dai.
Kato J; Yoshida T; Niwa T
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):A32. PubMed ID: 27094581
[No Abstract] [Full Text] [Related]
7. Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.
Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
Int Heart J; 2023; 64(2):316-320. PubMed ID: 37005323
[TBL] [Abstract][Full Text] [Related]
8. Kui jie qing in the treatment of chronic non-specific ulcerative colitis.
Wang B; Ren S; Feng W; Zhong Z; Qin C
J Tradit Chin Med; 1997 Mar; 17(1):10-3. PubMed ID: 10437236
[No Abstract] [Full Text] [Related]
9. Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Matsumoto T
Intern Med; 2019 Aug; 58(16):2299-2304. PubMed ID: 31118381
[TBL] [Abstract][Full Text] [Related]
10. Ulmus macrocarpa hance for the treatment of ulcerative colitis--a report of 36 cases.
Ye G; Cao Q; Chen X; Li S; Jia B
J Tradit Chin Med; 1990 Jun; 10(2):97-8. PubMed ID: 2392003
[No Abstract] [Full Text] [Related]
11. Effect of Oral Qing-Dai Medication on Pulmonary Arterial Pressure Levels in Patients With Ulcerative Colitis.
Orihara Y; Asakura M; Hida N; Kawai M; Sato T; Nishimura K; Masai K; Matsumoto Y; Okuhara Y; Goda A; Masuyama T; Nakamura S; Ishihara M
Circ J; 2020 Jul; 84(8):1339-1345. PubMed ID: 32595175
[TBL] [Abstract][Full Text] [Related]
12. Letter by Frumkin Regarding Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.".
Frumkin LR
Int Heart J; 2023 Nov; 64(6):1166. PubMed ID: 37967984
[No Abstract] [Full Text] [Related]
13. Response to the Letter by Frumkin Regarding the Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis".
Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
Int Heart J; 2023; 64(6):1167. PubMed ID: 38030296
[No Abstract] [Full Text] [Related]
14. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic non-specific colitis using Chinese herbal medicine and determination of plasma fibronectin].
Zhao H; Zhou JZ
Zhong Xi Yi Jie He Za Zhi; 1988 Aug; 8(8):464-5, 452. PubMed ID: 3248339
[No Abstract] [Full Text] [Related]
16. Screening of the optimized prescription from Suqingwan in terms of its therapeutic effect on DSS-induced ulcerative colitis by its regulation of inflammatory and oxidative mediators.
Shao J; Liu Z; Wang L; Song Z; Chang H; Han N; Yin J
J Ethnopharmacol; 2017 Apr; 202():54-62. PubMed ID: 28284792
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis on 1363 patients with nonspecific ulcerative colitis in China].
Qiao LH
Zhong Xi Yi Jie He Za Zhi; 1987 May; 7(5):308-11. PubMed ID: 3319219
[No Abstract] [Full Text] [Related]
18. Indole compounds may be promising medicines for ulcerative colitis.
Sugimoto S; Naganuma M; Kanai T
J Gastroenterol; 2016 Sep; 51(9):853-61. PubMed ID: 27160749
[TBL] [Abstract][Full Text] [Related]
19. A case report of drug-induced ischemic colitis accompanied by ulcerative colitis.
Zhou G; Xiong F; Yang X; Wang P
Gastroenterol Hepatol; 2021 Feb; 44(2):137-138. PubMed ID: 32718840
[No Abstract] [Full Text] [Related]
20. Traditional Chinese medicine combination therapy for patients with steroid-dependent ulcerative colitis: study protocol for a randomized controlled trial.
Zheng K; Shen H; Jia J; Lu Y; Zhu L; Zhang L; Shen Z
Trials; 2017 Jan; 18(1):8. PubMed ID: 28069051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
